Nukkleus Inc.
For the period ended Jun 30, 2025. Filed Aug 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 14, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Recent Sales of Unregistered Securities
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Except as set forth below, there were no sales of equity securities sold during the period covered by this Report that were not registered under the Securities Act and were not previously reported in a Current Report on Form 8-K filed by the Company.
On April 4, 2025, the Company entered into a settlement agreement with a former consultant of the Company. Pursuant to the terms of the settlement agreement, the Company issued 12,500 shares of common stock to the consultant.
On May 13, 2025, a consultant submitted a cashless exercise of 100,000 options granted in November 2024, which resulted in an issuance of 84,276 shares of common stock.
During the three months ended June 30, 2025, YA II PN, LTD. converted all principal and accrued interest on the $500,000 note issued December 3, 2024 for 260,300 shares of common stock.
The above issuance[s] did not involve any underwriters, underwriting discounts or commissions, or any public offering and we believe are exempt from the registration requirements of the Securities Act of 1933, as amended, by virtue of Section 4(a)(2) thereof.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.